S
Steven J. Nurkin
Researcher at Roswell Park Cancer Institute
Publications - Ā 62
Citations - Ā 5064
Steven J. Nurkin is an academic researcher from Roswell Park Cancer Institute. The author has contributed to research in topics: Colorectal cancer & Neoadjuvant therapy. The author has an hindex of 20, co-authored 57 publications receiving 3350 citations. Previous affiliations of Steven J. Nurkin include City of Hope National Medical Center & New York Hospital Queens.
Papers
More filters
Journal ArticleDOI
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Al B. Benson,Alan P. Venook,Lynette Cederquist,Emily Chan,Yi-Jen Chen,Harry S. Cooper,Dustin A. Deming,Paul F. Engstrom,Peter C. Enzinger,Alessandro Fichera,Jean L. Grem,Axel Grothey,Howard S. Hochster,Sarah E. Hoffe,Steven C. Hunt,Ahmed Kamel,Natalie Kirilcuk,Smitha S. Krishnamurthi,Wells A. Messersmith,Mary F. Mulcahy,James D. Murphy,Steven J. Nurkin,Leonard B. Saltz,Sunil Sharma,David Shibata,John M. Skibber,Constantinos T. Sofocleous,Elena M. Stoffel,Eden Stotsky-Himelfarb,Christopher G. Willett,Christina Wu,Kristina M. Gregory,Deborah A. Freedman-Cass +32 more
TL;DR: This portion of the NCCN Guidelines for Colon Cancer focuses on the use of systemic therapy in metastatic disease and considers treatment history, extent of disease, goals of treatment, the efficacy and toxicity profiles of the regimens, KRAS/NRAS mutational status, and patient comorbidities and preferences.
Journal ArticleDOI
Rectal cancer, version 2.2018 clinical practice guidelines in Oncology
Al B. Benson,Alan P. Venook,Mahmoud M. Al-Hawary,Lynette Cederquist,Yi Jen Chen,Kristen K. Ciombor,Stacey Cohen,Harry S. Cooper,Dustin A. Deming,Paul F. Engstrom,Jean L. Grem,Axel Grothey,Howard S. Hochster,Sarah E. Hoffe,Steven C. Hunt,Ahmed Kamel,Natalie Kirilcuk,Smitha S. Krishnamurthi,Wells A. Messersmith,Jeffrey A. Meyerhardt,Mary F. Mulcahy,James D. Murphy,James D. Murphy,Steven J. Nurkin,Leonard B. Saltz,Sunil Sharma,David Shibata,John M. Skibber,Constantinos T. Sofocleous,Elena M. Stoffel,Eden Stotsky-Himelfarb,Christopher G. Willett,Evan Wuthrick,Deborah A. Freedman-Cass,Kristina M. Gregory,Lisa A. Gurski +35 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in patients with rectal cancer.
Journal ArticleDOI
NCCN GuidelinesĀ® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines
Al B. Benson,Alan P. Venook,Mahmoud M. Al-Hawary,Lynette Cederquist,Yi Jen Chen,Kristen K. Ciombor,Stacey Cohen,Harry S. Cooper,Dustin A. Deming,Paul F. Engstrom,Ignacio Garrido-Laguna,Jean L. Grem,Axel Grothey,Howard S. Hochster,Sarah E. Hoffe,Steven C. Hunt,Ahmed Kamel,Natalie Kirilcuk,Smitha S. Krishnamurthi,Wells A. Messersmith,Jeffrey A. Meyerhardt,Eric D. Miller,Mary F. Mulcahy,James D. Murphy,Steven J. Nurkin,Leonard B. Saltz,Sunil Sharma,David Shibata,John M. Skibber,Constantinos T. Sofocleous,Elena M. Stoffel,Eden Stotsky-Himelfarb,Christopher G. Willett,Evan Wuthrick,Kristina M. Gregory,Deborah A. Freedman-Cass +35 more
TL;DR: The NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib are summarized.
Journal ArticleDOI
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Al B. Benson,Alan P. Venook,Mahmoud M. Al-Hawary,Mustafa A. Arain,Yi Jen Chen,Kristen K. Ciombor,Stacey Cohen,Harry S. Cooper,Dustin A. Deming,Linda Farkas,Ignacio Garrido-Laguna,Jean L. Grem,Andrew J. Gunn,J. Randolph Hecht,Sarah E. Hoffe,Joleen M. Hubbard,Steven C. Hunt,Kimberly L. Johung,Natalie Kirilcuk,Smitha S. Krishnamurthi,Wells A. Messersmith,Jeffrey A. Meyerhardt,Eric D. Miller,Mary F. Mulcahy,Steven J. Nurkin,Michael J. Overman,Aparna Raj Parikh,Hitendra Patel,Katrina S. Pedersen,Leonard B. Saltz,Charles Schneider,David Shibata,John M. Skibber,Constantinos T. Sofocleous,Elena M. Stoffel,Eden Stotsky-Himelfarb,Christopher G. Willett,Kristina M. Gregory,Lisa A. Gurski +38 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section as discussed by the authors.
Journal ArticleDOI
Rectal cancer, version 6.2020: Featured updates to the NCCN guidelines
Al B. Benson,Al B. Benson,Alan P. Venook,Alan P. Venook,Mahmoud M. Al-Hawary,Mahmoud M. Al-Hawary,Mustafa A. Arain,Mustafa A. Arain,Yi Jen Chen,Yi Jen Chen,Kristen K. Ciombor,Kristen K. Ciombor,Stacey Cohen,Stacey Cohen,Harry S. Cooper,Harry S. Cooper,Dustin A. Deming,Dustin A. Deming,Ignacio Garrido-Laguna,Ignacio Garrido-Laguna,Jean L. Grem,Jean L. Grem,Andrew Gunn,Sarah E. Hoffe,Sarah E. Hoffe,Joleen M. Hubbard,Joleen M. Hubbard,Steven C. Hunt,Steven C. Hunt,Natalie Kirilcuk,Natalie Kirilcuk,Smitha S. Krishnamurthi,Smitha S. Krishnamurthi,Wells A. Messersmith,Wells A. Messersmith,Jeffrey A. Meyerhardt,Jeffrey A. Meyerhardt,Eric D. Miller,Eric D. Miller,Mary F. Mulcahy,Mary F. Mulcahy,Steven J. Nurkin,Steven J. Nurkin,Michael J. Overman,Michael J. Overman,Aparna Raj Parikh,Aparna Raj Parikh,Hitendra Patel,Hitendra Patel,Katrina S. Pedersen,Katrina S. Pedersen,Leonard Saltz,Leonard Saltz,Charles Schneider,Charles Schneider,David Shibata,David Shibata,John M. Skibber,John M. Skibber,Constantinos T. Sofocleous,Constantinos T. Sofocleous,Elena M. Stoffel,Elena M. Stoffel,Eden Stotsky-Himelfarb,Eden Stotsky-Himelfarb,Christopher G. Willett,Christopher G. Willett,Alyse Johnson-Chilla,Alyse Johnson-Chilla,Lisa A. Gurski,Lisa A. Gurski +70 more
TL;DR: These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, clarifying the definition of rectum and differentiating the rectum from the sigmoid colon; the total neoadjuvant therapy approach for localized rectal cancer; and biomarker-targeted therapy for metastatic colorectal cancer.